4 ± 6.5 13.7 ± 6.2 -2.7 ± 3.6*

-11.0 ± 15.5* Total body water (L) 35.3 ± 4.4 35.4 ± 4.5 0.1 ± 0.9 0.2 ± 2.7 Extracellular fluid (L) 13.3 ± 1.7 13.3 ± 1.7 0.0 ± 0.5 0.0 ± 3.6 Alisertib in vivo Intracellular fluid (L) 22.0 ± 2.7 22.1 ± 2.8 0.1 ± 0.5 0.4 ± 2.3 Volume of the foot (L) 0.858 ± 1.205 0.908 ± 1.100 0.050 ± 0.116 6.9 ± 14.4 Results are presented as mean ± SD; * = P < 0.05, ** = P < 0.001. Haematological and biochemical measurements Haematocrit (HCT), plasma sodium [Na+], plasma urea, plasma osmolality, urine urea, urine specific gravity (USG) and urine osmolality pre- and Akt inhibitor Post-race measurements were determined in a subgroup of twenty-five athletes (16 men and 9 women) to investigate changes in hydration status (Table  3). These procedures were performed at the same time as the anthropometric measurements, before the start and directly after finishing the race. The recording procedure for pre- and post-race measurements was identical. After venipuncture of an antecubital vein, one Sarstedt S-Monovette (plasma gel, 7.5 mL) for chemical and one Sarstedt S-Monovette

(EDTA, 2.7 mL) for haematological analysis were cooled and sent to the laboratory and were analysed AR-13324 clinical trial within six hours. Haematocrit was determined using Sysmex XE 2100 (Sysmex Corporation, Japan), plasma [Na+] and plasma urea using a biochemical analyzer Modula SWA, Modul P + ISE (Hitachi High Technologies Corporation, Japan, Roche Diagnostic), and plasma osmolality using Arkray Osmotation (Arkray Factory, Inc., Japan). Samples of urine were collected in one Sarstedt monovette for urine (10 mL) and sent to the laboratory. Urine urea was determined using a biochemical analyzer Modula SWA, Modul P + ISE (Hitachi High Technologies Corporation, ifenprodil Japan, Roche Diagnostic), urine specific gravity using Au Max-4030 (Arkray Factory, Inc., Japan), and urine osmolality using Arkray Osmotation (Arkray Factory, Inc., Japan). Table 3 Haematological and urinary parameters (n = 25) Parameter Pre-race Post-race

Absolute change Change (%)   M ± SD M ± SD     Male ultra-MTBers(n = 16)         Haematocrit (%) 43.1 ± 3.3 42.6 ± 3.1 -0.5 ± 3.7 -0.7 ± 8.8 Plasma sodium (mmol/L) 138.2 ± 1.4 137.8 ± 2.3 -0.4 ± 2.9** -0.3 ± 2.1 Plasma urea (mmol/L) 6.1 ± 1.3 13.5 ± 4.1 7.4 ± 3.8** 124.0 ± 67.2 Plasma osmolality (mosmol/kg H2O) 289.4 ± 4.1 293.6 ± 4.4 4.2 ± 4.5** 1.5 ± 1.6 Urine urea (mmol/L) 239.3 ± 172.1 576.0 ± 78.0 336.7 ± 174.8** 298.0 ± 315.5 Urine osmolality (mosmol/kg H2O) 415.7 ± 190.3 776.7 ± 133.4 361.0 ± 184.4** 132.0 ± 132.4 Urine specific gravity (g/mL) 1.013 ± 0.002 1.022 ± 0.004 0.009 ± 0.004** 0.8 ± 0.3 Female ultra-MTBers (n = 9)         Haematocrit (%) 42.0 ± 2.7 40.0 ± 2.8 -2.0 ± 4.1 -4.5 ± 10.0 Plasma sodium (mmol/L) 137.4 ± 2.8 137.1 ± 1.8 -0.3 ± 3.0 -0.2 ± 2.